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Most human tumors, including most male genital tumors, exhibit an exponential increase in
incidence with advancing age of the host. This exponential age-incidence pattern can be
explained by the accumulation of mutations in the stem cells ofthe tissues oftumor origin. The
age-incidence pattern for testicular tumors, however, is unique with a large linear increase in
incidence from age 14 to 30 and a linear decline in incidence from age 30 to 60. After age 60, the
incidence of testicular tumors remains low and constant.
The probability of testicular tumorigenesis is determined by the susceptibility of male germ
cells to neoplastic mutation and/or the neoplastic mutagenicity of the male germ cell
environment. Since there is no evidence for an environmental mutagen which is specific for male
germ cells, and since male germ cells are unusually susceptible to mutation, we interpret the
variation in testicular tumor incidence with age as a reflection ofthe susceptibility ofmale germ
cells to neoplastic mutation. Cells are most susceptible to mutation during genome replication
and we propose a model for testicular tumorigenesis which is consistent with the available data
on male germ cell proliferation and with the data on testicular tumor incidence.
INTRODUCTION
The incidence ofmost human tumors increases continuously with advancing age of
the host [1-7]. We have found that when incidence data is normalized for differences
in frequency of tumor occurrence, the vast majority of human tumors exhibit very
similar age-incidence patterns [7]. Testicular tumors, however, do not conform to this
general pattern [8-12]. It is the purpose of this paper to describe recent and accurate
incidence data for male genital tumors in Connecticut, to compare the age-incidence
pattern for testicular tumors with the age-incidence patterns for other male genital
tumors, and to propose an explanation for the unique age-incidence pattern for
testicular tumors. The advantage of studying incidence data collected in Connecticut
is twofold: The small geographic boundaries minimize variation in exposure to
environmental carcinogens such as radiation, chemical pollutants, and possible
viruses, and the affluent urban population with its abundance of physicians tends to
minimize the danger of under-reporting and incorrect diagnosis.
MATERIALS AND METHODS
Data for the annual incidence of malignant tumors of the male bladder, testis,
prostate, penis, and other male genital loci from the beginning of 1968 through the
end of 1978 was collected by the Connecticut Tumor Registry, Hartford, Connecti-
cut. We were concerned with the variation in tumor incidence with hose age and not
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age-incidence patterns for differences in frequency of occurrence, the incidence data
was treated as described previously [7]. For each tumor, the annual incidence per
100,000 persons at each age was averaged between 1968 and 1979. Then, for each
tumor, this average annual incidence per 100,000 persons at each age was summed
over all ages to give total incidence. The percentage of this total incidence which
occurred at each age was then calculated (Fig. 1).
RESULTS
The normalized age-incidence patterns for male bladder and genital tumors other
than tumors of the testis are all very similar (Fig. 1). As a basis for comparison to the
normalized age-incidence pattern for testicular tumors, we calculated the average
normalized pattern among all male bladder and genital tumors other than tumors of
the testis. In Fig. 2, this average pattern is displayed on a logarithmic incidence scale.
The difference between the data in Fig. 2 and the least-squares straight line is
insignificant (p > 0.3) according to the chi-square test. We conclude that the
incidence of male bladder and genital tumors other than tumors ofthe testis increases
exponentially with age and, on the average, can be described by the following
equation:
log % total incidence = 0.042 (age) - 1.99
The normalized age-incidence pattern for tumors of the testis is unique (Fig. 1).
The incidence oftesticular tumors increases linearly from age 14to some age between
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FIG. 1. Percentage of total incidence of tumors of the male bladder (04023 cases), testis (@512 cases),
penis (Cl42 cases), prostate (o8102 cases), and other male genital tumors (A43 cases) which occurred per
100,000 persons at each age in Connecticut from 1968 through 1978.
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FIG. 2. Percentage of total incidence averaged for tumors of the male bladder, penis,
prostate, and other male genital tumors excluding tumors of the testis which occurred per
100,000 persons at each age in Connecticut from 1968 through 1978 and the least-squares
straight line.
29 and 34. Points on the least-squares straight line describing the data between ages
14 and 29, for instance, are not significantly different (p > 0.3) from the data points
in Fig. 1, according to the chi-square test. Thus the incidence of testicular tumors
between ages 14and 29 can be described bytheequation for the least-squares straight
line:
% total incidence = 0.884 (age) - 12.66
The incidence of testicular tumors decreases linearly from age 34 to some age
between 59 and 69. Points on the least-squares straight line describing the data
between ages 34 and 59, forinstance, are notsignificantly different(p > 0.3) from the
data points in Fig. 1, according to thechi-square test. Thus the incidence oftesticular
tumors between ages 34 and 59 can be describedbytheequation for the least-squares
straight line:
% total incidence = -0.360 (age) + 24.57
The incidence of testicular tumors is rather constant at ages greater than 60 and
there is a very small peak in incidence (less than I percent of total testicular tumor
incidence) at ages less than five (Fig. 1).
DISCUSSION
The normalized age-incidence patterns for male bladder and genital tumors other
295than tumors of the testis (Fig. 2) resemble the normalized age-incidence patterns for
the vast majority of human tumors and are consistent with the model previously
proposed [7]: mutations which accumulate during normal aging cause or facilitate
neoplastic mutations. Cells are most susceptible to mutation during genome replica-
tion [13] and the accumulation of mutations during aging by lifelong genome
replication is consistent with current models for both epithelial [13] and hematopoie-
tic [14-16] stem cell propagation.
Our age-incidence pattern for testicular tumors in Connecticut resembles the recent
age-incidence pattern for testicular tumors in Los Angeles [8] and older age-mortality
patterns for these tumors [9-10]. The advantage of our normalized age-incidence
pattern for testicular tumors is that it permits comparison with recent normalized
age-incidence patterns for other tumors. On the basis of such a comparison, the linear
age-incidence pattern for testicular tumors is found to be unique among male genital
and bladder tumors (Fig. 1) as well as among all other tumors studied [7]. The unique
age-incidence pattern for testicular tumors is incompatible with the model for
carcinogenesis previously proposed [7].
The vast majority (> 94 percent) of testicular tumors are of germ cell origin [11].
We consider the probability of testicular tumorigenesis to be determined by the
susceptibility of germ cells to neoplastic mutation and/ or the neoplastic mutagenicity
of the germ cell environment. Although some aspects of epidemiology have been
interpreted as suggesting a role for an environmental agent in testicular tumorigenesis
[20-23], there is no evidence for any specific etiologic agent in the environment [9,19].
The finding that tumors of male genital loci other than the testis display conventional
exponential age-incidence patterns (Fig. 2) indicates that if environmental mutage-
nicity is the primary determinant of the unique age-incidence pattern for testicular
tumors, the mutagen must be specific for the testis rather than the male genital area.
This requirement for exquisite tissue specificity would exclude radiation and known
chemical carcinogens.
We have concluded that tissue susceptibility to neoplastic mutation is the domi-
nant determinant of the age-incidence pattern for the vast majority of human tumors
[7,24] and we suggest that the unique age-incidence pattern for testicular tumors can
best be interpreted as a reflection of the variation with age in germ cell susceptibility
to neoplastic mutation.
Continuous genome replication as exhibited by epithelial [13] and hematopoietic
[14-16] stem cells would yield an exponential increase in susceptibility to neoplastic
mutation with advancing age of the host [7,24]. The linear increase and decline in
testicular tumor incidence between ages 14 and 59(Fig. 1) suggests a unique variation
in male germ cell susceptibility to neoplastic mutation.
The beginning of the linear increase in incidence of germ cell tumors at age 14 (Fig.
1) coincides with the beginning of rapid germ cell proliferation at puberty [25-26].
Rapid proliferation is accompanied by rapid genome replication and increased
susceptibility to mutation [13]. Male germ cells are unique in that they serve no
purpose for the host unless they are emitted. Because male germ cells are designed for
emission, mutation repair mechanisms can be lax without conferring a survival
disadvantage upon the host. Indeed male germ cell mutations must be common since
it is not abnormal to find 30 percent of the emitted spermatozoa to be atypically
formed [27]. We propose a model for male germ cell proliferation (Fig. 3) to account
for a linear variation with age in male germ cell susceptibility to neoplastic mutation.
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FIG. 3. Model for testicular germ cell proliferation:e, primordial germ cell
and/or prospermatogonium;aD, primitive spermatogonium, i.e., Clermont's dark
type A [28-29]; o, proliferating spermatogonium, i.e., Clermont's pale type A
[28-29]; e, committed spermatogonium, i.e., Clermont's type B [28-29]. Pri-
mordial germ cells and prospermatogonia proliferate before birth [25]. At birth
some spermatogonia are present [25] but the number of spermatogonia per testis
remains rather constant until age 10[25-26]. Between ages 10 and 16, the number
of spermatogonia per testis increases exponentially [26]. We attribute the linear
increase in tumor incidence between ages 14 and 30 to a linear rate of activation
of clones of primordial germ cells or prospermatogonia. Most testicular tumors
occurring between ages 14 and 30 resemble primordial germ cells histologically
[11,30-31]. Once activated, clones of spermatogonia would proliferate according
to the mechanism described by Clermont [28-29]. Stem cells have a finite life span
[32] and we attribute the lineardecline in tumor incidence between ages 30 and 59
to a linear rate of inactivation of the clones of proliferating spermatogonia.
Similar rates of activation and inactivation of clones of spermatogonia would
explain the similarity between the rates of increase and decline in tumor
incidence. Because committed spermatogonia are destined to become spermato-
zoa [28-29], they have a minimal capacity for division and thus a minimal
opportunity to acquire neoplastic mutations [13]. This pattern of germ cell
proliferation is consistent with testicular tumor histology which resembles
spermatogonia after age 30[11,30-31] and committed spermatogonia after age 60
[11,30-31]. The absence of proliferating spermatogonia after age 60 is consistent
with the diminished fertility of elderly men [33] and can explain the low and
constant rate of testicular tumor incidence after age 60.
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